Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP639670.RAVTrR21plm-9WL-fMYEUuvf3pbpQ0VJZ3rV2aHe6deZE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP639670.RAVTrR21plm-9WL-fMYEUuvf3pbpQ0VJZ3rV2aHe6deZE130_assertion type Assertion NP639670.RAVTrR21plm-9WL-fMYEUuvf3pbpQ0VJZ3rV2aHe6deZE130_head.
- NP639670.RAVTrR21plm-9WL-fMYEUuvf3pbpQ0VJZ3rV2aHe6deZE130_assertion description "[Therefore, targeting inflammation along with the newly identified targets, such as MMP10 and S100A15, represents promising therapeutic strategies to treat SCCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP639670.RAVTrR21plm-9WL-fMYEUuvf3pbpQ0VJZ3rV2aHe6deZE130_provenance.
- NP639670.RAVTrR21plm-9WL-fMYEUuvf3pbpQ0VJZ3rV2aHe6deZE130_assertion evidence source_evidence_literature NP639670.RAVTrR21plm-9WL-fMYEUuvf3pbpQ0VJZ3rV2aHe6deZE130_provenance.
- NP639670.RAVTrR21plm-9WL-fMYEUuvf3pbpQ0VJZ3rV2aHe6deZE130_assertion SIO_000772 24029918 NP639670.RAVTrR21plm-9WL-fMYEUuvf3pbpQ0VJZ3rV2aHe6deZE130_provenance.
- NP639670.RAVTrR21plm-9WL-fMYEUuvf3pbpQ0VJZ3rV2aHe6deZE130_assertion wasDerivedFrom befree-20140225 NP639670.RAVTrR21plm-9WL-fMYEUuvf3pbpQ0VJZ3rV2aHe6deZE130_provenance.
- NP639670.RAVTrR21plm-9WL-fMYEUuvf3pbpQ0VJZ3rV2aHe6deZE130_assertion wasGeneratedBy ECO_0000203 NP639670.RAVTrR21plm-9WL-fMYEUuvf3pbpQ0VJZ3rV2aHe6deZE130_provenance.